About Xellia Pharmaceuticals AS
Xellia Pharmaceuticals is a fully integrated specialty pharmaceutical company focusing on the global anti-infective market.
2
Transactions
Sign up to view
$958M
Deal Value
Sign up to view
Investors
Current Investors
Novo A/S
••••••••
Past Investors
••••••••
••••••••
Investment Details
2 Transactions
| Trans. ID | Investment Date | Exit Date | Investor(s) | Deal Size (M) | Seller(s) |
|---|---|---|---|---|---|
Xellia Pharmaceuticals AS M&A Activity
| # | Company | Transaction Date | Close Date | Sector | Country |
|---|---|---|---|---|---|
|
|
|||||
|
|
|||||
|
|
|||||
|
|
Key Executives & Professionals
Frequently Asked Questions
What does Xellia Pharmaceuticals AS do?
Xellia Pharmaceuticals is a fully integrated specialty pharmaceutical company focusing on the global anti-infective market.
Where is Xellia Pharmaceuticals AS headquartered?
Xellia Pharmaceuticals AS is headquartered in Oslo, Norway.
When was Xellia Pharmaceuticals AS founded?
Founded year information for Xellia Pharmaceuticals AS is available on AcquityData.
What sector is Xellia Pharmaceuticals AS in?
Xellia Pharmaceuticals AS operates in the Life Science sector.
Who are the investors in Xellia Pharmaceuticals AS?
Current investors in Xellia Pharmaceuticals AS include Novo A/S. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Xellia Pharmaceuticals AS been involved in?
Xellia Pharmaceuticals AS has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.
Unlock the full Xellia Pharmaceuticals AS profile
Ownership & Investors
M&A History
Financials
Key Executives
Advisors & Lenders
Access Xellia Pharmaceuticals AS's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.
Start Free Trial